DAVID WEINER was named executive vice president of The Wistar Institute, director of the Vaccine Center, and the W. W. Smith Endowed Chair in Cancer Research. Weiner will also contribute tumor immunology-focused research as a professor in Wistar’s Translational Tumor Immunology program. Previously, Weiner was a professor of pathology and laboratory medicine at the University...
In this episode of The Cancer Letter Podcast, Paul Goldberg, editor and publisher of The Cancer Letter, Jacquelyn Cobb, managing editor, discuss the Sept. 23 meeting of the FDA Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee, during which the panel voted in favor of Galleri, the multi-cancer detection test from GRAIL Inc., to become the first multi-cancer detection test to receive regulatory approval.
